[{"NetIncomeLoss_1_Q2_USD":2011133.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":23012000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":110222.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GeneralAndAdministrativeExpense_1_Q2_USD":336563.0,"GeneralAndAdministrativeExpense_2_Q2_USD":621725.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_2_Q2_USD":33923.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Liabilities_0_Q2_USD":35495455.0,"Cash_0_Q2_USD":278774.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2830970.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":199055.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q2_USD":0.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_2_Q2_USD":90000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-434781.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-20397000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":-2440670.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":15450.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-15450.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":345014002.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":2445914.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":20407430.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":790.0,"RestrictedInvestmentsPercentOfNetAssets_0_Q2_pure":0.15,"PrepaidExpenseCurrent_0_Q2_USD":214152.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-811997.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":17433333.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_1_Q2_USD":12000.0,"AssetsCurrent_0_Q2_USD":492926.0,"NetIncomeLoss_2_Q2_USD":19595433.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q2_USD":0.0,"ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_2_Q2_USD":0.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":11.5,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":278774.0,"AssetsNet_0_Q2_USD":184000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"AccountsPayableCurrent_0_Q2_USD":199055.0,"LiabilitiesCurrent_0_Q2_USD":408455.0,"NetAssetValuePerShare_0_Q2_USD":10.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-343601.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-359051.0,"TaxesPayableCurrent_0_Q2_USD":99178.0,"StockholdersEquity_0_Q2_USD":5000003.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":23012000.0,"DeferredTaxAssetsValuationAllowance_0_Q2_USD":141000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":345506928.0,"PreferredStockValue_0_Q2_USD":null,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"Assets_0_Q2_USD":345506928.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"SaleOfStockPricePerShare_0_Q2_USD":10.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":305011470.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":2167770.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-234628.0,"Ticker":"LUXA","CIK":"1823767","name":"LUX HEALTH TECH ACQUISITION CORP.","OfficialName":"Lux Health Tech Acquisition Corp. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"426075000.0","Country":"United States","Sector":"Consumer Durables","Industry":"Consumer Electronics\/Appliances","Market":"NASDAQ","SP500":"nan","filed":"20210813"}]